Page 102 | Certara

Press Coverage

Accelerating Market Access with Data-Driven Payer Engagement

Using data visualizations to improve access to payers. With the switch to more digital environments,…

CertaraOctober 25, 2022

Pediatrician examining cute baby in clinic, closeup

On-Demand Webinar

Applications of PBPK modelling for regulatory submissions: case studies involving DDIs, transporters and special populations

Over the past two decades, there have been transformative changes in our approach to using…

CertaraOctober 20, 2022

Press Coverage

Simultaneous FDA & EMA Submissions for Drug Approvals

Is there a better way? The question always breeds critical thinking and often leads to…

CertaraOctober 19, 2022

On-Demand Webinar

RAPS sponsored webcast: The EU Clinical Trials Regulation – Challenges Drug Developers Faced in the First 6 months

Join us on November 10th for this webcast being held in partnership with RAPS. The…

CertaraOctober 17, 2022

Blog

PBPK Modeling & Simulation of Therapeutic Oligonucleotides from Bench to Bedside

Next generation therapeutics Oligonucleotide drugs are unique among therapeutic modalities in that they don’t engage…

CertaraOctober 14, 2022

Fact Sheet

PK Submit™ Overview

Learn how PK Submit accelerates NCA workflows and ensures regulatory compliance.

CertaraOctober 12, 2022

Announcement

Certara Announces New Release of PK Submit

PRINCETON, N.J.— October 12, 2022 – Certara, Inc., a global leader in drug development software,…

CertaraOctober 12, 2022

Blog

The Growing Value of Quantitative Systems Pharmacology (QSP)

Gain a foundational understanding of QSP in this 101-level article with examples of QSP applied…

CertaraOctober 7, 2022

On-Demand Webinar

How to Define & Measure Clinical Endpoints to Optimize Your Oncology Drug Dosing

Historically, the dosing strategy for oncology drugs focused on the maximum tolerated dose. This has…

CertaraOctober 5, 2022

Blog

Choosing a Clinical Trial Transparency and Disclosure Vendor: Your Complete Checklist

Choosing the right technology and services vendor to support your organization’s transparency and disclosure (T&D)…

CertaraOctober 4, 2022

Accelerating Market Access with Data-Driven Payer Engagement

Applications of PBPK modelling for regulatory submissions: case studies involving DDIs, transporters and special populations

Simultaneous FDA & EMA Submissions for Drug Approvals

RAPS sponsored webcast: The EU Clinical Trials Regulation – Challenges Drug Developers Faced in the First 6 months

PBPK Modeling & Simulation of Therapeutic Oligonucleotides from Bench to Bedside

PK Submit™ Overview

Certara Announces New Release of PK Submit

The Growing Value of Quantitative Systems Pharmacology (QSP)

How to Define & Measure Clinical Endpoints to Optimize Your Oncology Drug Dosing

Choosing a Clinical Trial Transparency and Disclosure Vendor: Your Complete Checklist

Newsletter sign up

Quick links

Solutions

Contact